T. Rowe Price Associates
NPTN

T. Rowe Price Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

T. Rowe Price Associates’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,083,293
Closed -$6.81M – 2566
2019
Q1 		$6.81M Buy
+1,083,293
New +$7.59M ﹤0.01% 1366
2017
Q4 		– Sell
-19,000
Closed -$106K – 2627
2017
Q3 		$106K Hold
19,000
– – ﹤0.01% 2493
2017
Q2 		$147K Buy
19,000
+4,200
+28% +$35.5K ﹤0.01% 2435
2017
Q1 		$133K Hold
14,800
– – ﹤0.01% 2460
2016
Q4 		$160K Buy
+14,800
New +$197K ﹤0.01% 2416

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

T. Rowe Price Associates's NPTN Position: Q2 2019 in Review

T. Rowe Price Associates sold out of NEOPHOTONICS CORP (NPTN) in Q2 2019, closing a stake of 1,083,293 shares — an estimated $6.81M sold.

T. Rowe Price Associates first reported a position in NPTN in Q4 2016 and held it in 5 quarters. The position peaked at $6.81M in Q1 2019. 113 funds tracked by Wall St. Rank hold NPTN as of Q2 2019.

  • T. Rowe Price Associates reported no remaining NEOPHOTONICS CORP position as of Q2 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,083,293 NEOPHOTONICS CORP shares in Q2 2019, an estimated $6.81M.
  • T. Rowe Price Associates first reported a position in NEOPHOTONICS CORP in Q4 2016 and held it in 5 quarters.
  • T. Rowe Price Associates's NEOPHOTONICS CORP position peaked at $6.81M in Q1 2019.
  • 113 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2019.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.